Free Trial
NASDAQ:AADI

Aadi Bioscience (AADI) Stock Price, News & Analysis

Aadi Bioscience logo
$1.98 -0.01 (-0.50%)
As of 07/7/2025

About Aadi Bioscience Stock (NASDAQ:AADI)

Key Stats

Today's Range
$1.92
$2.02
50-Day Range
$1.48
$2.09
52-Week Range
$1.21
$3.81
Volume
164,896 shs
Average Volume
252,832 shs
Market Capitalization
$48.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.67
Consensus Rating
Hold

Company Overview

Aadi Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

AADI MarketRank™: 

Aadi Bioscience scored higher than 13% of companies evaluated by MarketBeat, and ranked 877th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aadi Bioscience has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Aadi Bioscience has received no research coverage in the past 90 days.

  • Read more about Aadi Bioscience's stock forecast and price target.
  • Earnings Growth

    Earnings for Aadi Bioscience are expected to grow in the coming year, from ($2.04) to ($0.94) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aadi Bioscience is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aadi Bioscience is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aadi Bioscience has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aadi Bioscience's valuation and earnings.
  • Short Interest

    There is no current short interest data available for AADI.
  • Dividend Yield

    Aadi Bioscience does not currently pay a dividend.

  • Dividend Growth

    Aadi Bioscience does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AADI.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Aadi Bioscience this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for AADI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Aadi Bioscience to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aadi Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    37.30% of the stock of Aadi Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.08% of the stock of Aadi Bioscience is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aadi Bioscience's insider trading history.
Receive AADI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter.

AADI Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

AADI Stock Analysis - Frequently Asked Questions

Aadi Bioscience's stock was trading at $3.15 at the start of the year. Since then, AADI shares have decreased by 37.1% and is now trading at $1.98.

Aadi Bioscience, Inc. (NASDAQ:AADI) announced its earnings results on Tuesday, March, 18th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.37. The company earned $7.24 million during the quarter, compared to the consensus estimate of $7.45 million. Aadi Bioscience had a negative net margin of 246.06% and a negative trailing twelve-month return on equity of 71.87%.
Read the conference call transcript
.

Aadi Bioscience's stock reverse split before market open on Friday, August 27th 2021.The 1-15 reverse split was announced on Thursday, August 26th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 25th 2021. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of AADI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aadi Bioscience investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Moderna (MRNA), NVIDIA (NVDA) and Alphabet (GOOG).

Company Calendar

Last Earnings
3/18/2025
Today
7/08/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AADI
CIK
1422142
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$1.75
Low Price Target
$1.50
Potential Upside/Downside
-15.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.76 million
Net Margins
-246.06%
Pretax Margin
-246.06%

Debt

Sales & Book Value

Annual Sales
$25.07 million
Price / Cash Flow
N/A
Book Value
$4.29 per share
Price / Book
0.46

Miscellaneous

Free Float
15,485,000
Market Cap
$48.90 million
Optionable
Optionable
Beta
0.68
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AADI) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners